Semi-parametric modelling for costs of health care technologies

Statistics in Medicine

Volumn 24, Issue 20, 2005, Pages 3171-3184

  Conigliani, C ^a   Tancredi, Andrea ^b  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cost data; Extreme value theory; Generalized Pareto distribution; Health economics; MCMC

Indexed keywords

BUDESONIDE; TRIAMCINOLONE ACETONIDE;

ARTICLE; ASTHMA; BAYES THEOREM; BIOSTATISTICS; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MATHEMATICAL COMPUTING; MEDICAL TECHNOLOGY; PARAMETRIC TEST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BAYES THEOREM; HEALTH CARE COSTS; HUMANS; MARKOV CHAINS; MODELS, ECONOMIC; MODELS, STATISTICAL; MONTE CARLO METHOD; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 27144439506     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2012     Document Type: Article

References (16)

1. O'Hagan A, Stevens JW. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Statistical Methods in Medical Research 2002; 11:469-490.
2. O'Hagan A, Stevens JW. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? Health Economics 2003; 12:33-49.
3. Nixon RM, Thompson SG. Parametric modelling of cost data in medical studies. Statistics in Medicine 2004; 23:1311-1331.
4. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? British Medical Journal 2000; 329:1197-1200.
5. Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. Journal of Health Service Research Policy 1998; 3:233-245.
6. Tancredi A, Anderson CW, O'Hagan A. A Bayesian model for threshold uncertainty in extreme value theory. Working paper 2002, 12, Dipartimento di Scienze Statistiche, Università di Padova. Available at http://3w.eco.uniromal.it/utenti/tancredi/, submitted.
7. Coles SG. An Introduction to Statistical Modeling of Extreme Values. Springer: London, 2001.
8. Robert CP. Discretization and MCMC Convergence Assessment. Lecture Notes in Statistics, vol. 135. Springer: New York, 1998.
9. Robert CP, Casella G. Monte Carlo Statistical Methods. Springer: New York, 1999.
10. Coles SG, Tawn JA. A Bayesian analysis of extreme rainfall data. Applied Statics 1996; 45:463-478.
11. Coles SG, Pericchi L. Anticipating catastrophes through extreme value modelling. Applied Statics 2003; 52: 405-416.
12. Green PJ. A Primer on Markov chain Monte Carlo. In Complex Stochastic Systems, Barndorff-Nielsen OE, Cox DR, Kluppelberg C (eds). Chapman & Hall: London, 2000.
13. Rubin DB. The Bayesian bootstrap. Annals of Statistics 1981; 9:130-134.
14. Al MJ, van Hout BA. A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty. Health Economics 2000; 9:599-609.
15. O'Hagan A, Stevens JW. A framework for cost-effectiveness analysis from clinical trial data. Health Economics 2001; 10:302-315.
16. Fernandez C, Steel MFJ. On the dangers of modelling through continuous distributions: a Bayesian perspective. In Bayesian Statistics 6, Bernardo JM, Berger JO, Dawid AP, Smith AFM (eds). Oxford University Press: Oxford, 1999.